Therapy of sinuorbital aspergillosis with amphotericin B colloidal dispersion

Mycoses

Volumn 41, Issue 7-8, 1998, Pages 287-292

  Rieske, K ^a,b   Handrick, W ^a   Muller H ^a   Sterker, I ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

Colloidal dispersed amphotericin B.; Sinuorbital fungal infection

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B CHOLESTEROL SULFATE; CEFTAZIDIME; CYTARABINE; FLUCLOXACILLIN; FLUCYTOSINE; IMIPENEM; IMMUNOGLOBULIN G; INTRALIPID; MITOXANTRONE; TIOGUANINE;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ALLOGENIC BONE MARROW TRANSPLANTATION; ANTIBIOTIC THERAPY; ARTICLE; ASPERGILLOSIS; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CHRONIC SINUSITIS; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; ORAL DRUG ADMINISTRATION; ORBIT INFECTION; PRIORITY JOURNAL; SINUSITIS;

EID: 0031775514     PISSN: 09337407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1439-0507.1998.tb00340.x     Document Type: Article

References (28)

1. Berkow, R. L., Weismann, St. J., Provisor, A. J., Weetman, R. M. & Baehner, R. L. (1983) Invasive aspergillosis of paranasal tissues in children with malignancies. J. Pediatr. 103, 49-53.
2. Polak-Wyss, A. (1989) Die antimykotische Chemotherapie Opportunistischer Pilz-Infektionen. Basle: Editiones Roche, pp. 91-94.
3. Baydala, L. T., Yanofsky, R., Akabuti, J. & Wenman, W. M. (1988) Aspergillosis of the nose and paranasal sinuses in immunocompromised children. Can. Med. Assoc. J. 138, 927-928.
4. Hakim, S. M. (1993) Management of invasive aspergillosis with itraconazole. Br. J. Clin. Pract. 47, 312-314.
5. Jennings, T. S. & Hardin, T. C. (1993) Treatment of aspergillosis with itraconazole. Ann. Pharmacoth. 27, 1206-1211.
6. Simon, C. & Stille, W. (1997) Antibiotika-Therapie in Klinik und Praxis. 9. Stuttgart: Aufl. Schattaucr, pp. 595-603.
7. Boeckh, M., Höffken, G. & Lode, H. (1989) Spektrum pulmonaler Manifestationen von Aspergillosen. Dt. med. Wochenschr. 114, 1706-1709.
8. Daghistani, K. J., Jamal, T. S., Zaher, S. & Nassif, O. I. (1992) Allergic Aspergillus sinusitis with proptosis J. Laryngol. Otol. 106, 799-803.
9. Heizmann, R. (ed.) (1993) Systemische Pilzinfektionen: Diagnostik, Prophylaxe und Therapie. Stuttgart: Wiss. Verl.-Ges.
10. Schulze-Berge, A., Sonntag, H.-G. & Kappe, R. (1994) Evaluation of seven commercially available serodiagnostic tests for invasive aspergillosis. J. Infect. 28, 57-58.
11. Mayer, J.-M., Nimer, L. & Carroll, K. (1992) Isolated pulmonary Aspergillus infection in cardiac transplant recipients: case report and review. Clin. Inject. Dis. 15, 678-700.
12. Renovanz, H.-D. (1985) Mykosen der Orbita und des Auges. Wien. med. Wochenschr. 135, 81-84.
13. Denning, D. W. (1994) Treatment of invasive aspergillosis. J. Infect. 28 (Suppl. 1), 25-33.
14. Lipp, H. P., Schuler, U., Saal, J. & Schaaf, D. (1993) Amphotericin B in Fettemulsionen. Arzneimitteltherapie 11, 319-326.
15. Moreau, Ph., Milpied, N., Fayette, N. & Ramée, & Harousseau, J. L. (1992) Reduced renal toxicity and improved clinical tolerance of amphotericin B mixed with INTRALIPID® compared with conventional amphotericin B in neutropenic patients. J. Antimicrob. Chemoth. 30, 535-541.
16. Bowden, R. A., Cays, M. & van Burik, J.-A. (1992) Phase I study of amphotericin B colloidal dispersion (ABCD, Amphocil™) for the treatment of invasive fungal infection after marrow transplant. 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy XAAC. Anaheim (USA).
17. Meunier, F. (1994) Alternative modalities of administering amphotericin B: current issues. J. Infect. 28, 51-56.
18. Mustafa, M. M., Sandler, E. S., Bernini, J. C. & Aquino, V. M. (1994) Amphotericin B colloidal dispersion therapy for invasive mycosis: report of successful therapy in two pediatric patients. Pediatr. Infect. Dis. J. 13, 326-328.
19. Stevens, D. A. (1994) Overview of amphotericin B colloidal dispersion (Amphocil®). J. Infect. 28, S1, 45-49.
20. Branch, R. A. (1988) Prevention of amphotericin B-induced renal impairment. Arch. Int. Med. 148, 2389-2394.
21. Fielding, R. M., Singer, A. W., Wang, L. H., Barbar, S. & Guo, L. S. S. (1992) Relationship of pharmacokinetics and drug distribution in tissue to increased safety of amphotericin B colloidal dispersions in dogs. Antimicrob. Ag. Chemoth. 36, 299-307.
22. Gardner, M. L., Godley, P. J. & Wasan, S. M. (1990) Sodium loading treatment for amphotericin B-induced nephrotoxicity. Ann. Pharmacoth. 24, 940-945.
23. Lode, H. (1993) †bersicht: Amphotericin B eine Standortbestimmung. Z. Chemother. Nov./Dez., 41-44.
24. Zuckerman, J. M. & Tunkel, A. R. (1994) Itraconazole: a new triazole antifungal agent. Infect. Contr. Hosp. Epid. 15, 397-410.
25. Karp, J. E., Merz., W. G. & Dick, J. D. (1994) Management of infections in neutropenic patients: new opportunities and emerging challenges. Curr. Op. Infect. Dis. 7, 430-435.
26. Creemers, G. J., Slingerland, R. & Hugenbeek, A. (1993) Necrotizing bronchial aspergillosis in a patient with acute yelocytic leukemia: a case report. Netherl. J. Med. 43, 121-E124.
27. Oppenheim, B. A., Herbrecht, R. & Kusne, S. (1995) The safety and efficacy of amphotericin B colloidal dispersion in the treatment of invasive mycoses. Clin. Infect. Dis. 21, 1145-1153.
28. White, M. H., Anaissie, E. J., Kusne, S., et al. (1997) Amphotericin B colloidal dispersion vs. amphotericin B as therapy for invasive aspergillosis. Clin. Infect. Dis, 24, 635-642.